GL1X · GenesisL1 explorer

Research workbench

Structure of a dimeric anti-HER2 single domain antibody

Analyse Structure of a dimeric anti-HER2 single domain antibody in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3QYC
Type
protein
Length
248 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vh domain of IgG molecule
Pockets
4 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVh domain of IgG moleculeprotein1257% helix, 46% strand—
BVh domain of IgG moleculeprotein1235% helix, 46% strand—

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11140.460.7819empty
2720.410.8014empty
3720.340.7610empty
4530.240.7212empty

Interfaces

1 interface between chains.

  • A–B · 1184 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 3QYC · Structure of a dimeric anti-HER2 single domain antibody · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.